Strong Corp- a 175,000$ Financing Avivagen Inc. Announces Closing of Second Tranche of a Private Placement of Shares
OTTAWA, Ontario -- (Business Wire) --
Avivagen Inc. (TSXV:VIV) ("Avivagen" or the "Company"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that it has closed the second tranche (the "Second Tranche") of its previously announced non-brokered private placement financing (the "Offering")through the issuance of common shares of the Company (each, a "Common Share") at a price of $0.20 per Share (the "Offering Price") (for more information about the Offering and the first tranche thereunder, please see the Company's news release dated October 21, 2022 for more details.
The Company issued 875,000 Common Shares, for aggregate gross proceeds of $175,000 in the Second Tranche. In the aggregate of all two tranches of the Offering, the Company issued 3,025,000 Common Shares for gross proceeds of $605,000.